Bemegride

Bemegride
Clinical data
Trade namesMigimide, others
Other namesMethetharimide
β,β-methylethylglutarimide
AHFS/Drugs.comInternational Drug Names
ATC code
Legal status
Legal status
  • AU: S4 (Prescription only)
Identifiers
  • 4-ethyl-4-methylpiperidine-2,6-dione
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.000.535 Edit this at Wikidata
Chemical and physical data
FormulaC8H13NO2
Molar mass155.197 g·mol−1
3D model (JSmol)
Melting point127 °C (261 °F)
  • O=C1NC(=O)CC(CC)(C1)C
  • InChI=1S/C8H13NO2/c1-3-8(2)4-6(10)9-7(11)5-8/h3-5H2,1-2H3,(H,9,10,11) checkY
  • Key:ORRZGUBHBVWWOP-UHFFFAOYSA-N checkY
  (verify)

Bemegride (trademarked as Megimide) is a central nervous system stimulant.[1] The drug was first made in 1911.[2] It has been used in hypnotic overdose.[1]

As with other chemoreceptor agonists, it is a potent emetic at doses above those normally used in management of barbiturate overdose although emesis and aspiration are a concern during treatment.

It is a controlled substance in some countries.[1]

  1. ^ a b c Hofmeister A (2000). "Analeptics". Ullmann's Encyclopedia of Industrial Chemistry: 1–2. doi:10.1002/14356007.a02_267. ISBN 3527306730.
  2. ^ Thole FB, Thorpe JF (1911). "LIII.—The formation and reactions of iminocompounds. Part XV. The production of imino-derivatives of piperidine leading to the formation of the ββ-disubstituted glutaric acids". Journal of the Chemical Society, Transactions. 99: 422–448. doi:10.1039/CT9119900422.